LIVE
Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video
Fauci Defends FDA for Rescinding Authorization of Monoclonal Antibodies -- 'Risk of a Potential Adverse Effect with Essentially No Benefit'
Politics
January 25, 2022
This article is being updated.
Previous article: Harvard-Harris Poll: Majority of Voters Say Donald Trump a Better President than Biden
Prev
Next article: Poll: 59 Percent Disapprove of the Democrat-Led Congress
Next
via
Breitbart
January 25th 2022
MixedTimes.com
Politics
Fauci Defends FDA for Rescinding Authorization of Monoclonal Antibodies -- 'Risk of a Potential Adverse Effect with Essentially No Benefit'
Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video